Fresh Pyrazoline Compound Slows Cancer Cells

Scientists keep searching for better ways to stop cancer because it still takes many lives. They noticed that pyrazoline molecules can be changed easily, which makes them good candidates for new drugs.

To test this idea, they took chalcone pieces and mixed them with phenylhydrazine. This reaction gave eight different pyrazoline derivatives that each have a chlorothiophene group. The process worked well, producing the compounds in yields ranging from fifty‑nine to ninety‑four percent. To be sure what they made, they used infrared spectroscopy, mass spec, and both proton and carbon NMR.

Next, they added the new compounds to three kinds of cancer cells—T47D, MCF7, and WiDr—and also to normal Vero cells. Using the MTT assay they measured how much each substance slowed cell growth. The most active one was compound 2g, which needed only about nineteen point six micrograms per milliliter to halve the WiDr cell population. Compared to normal cells, its selectivity index was over six hundred, showing it harms cancer cells far more than healthy ones.

Computer docking studies showed that compound 2g fits tightly into the COX‑2 enzyme, with a binding energy of roughly minus ten point five kilocalories per mole. The predicted absorption, distribution, metabolism and excretion traits looked favorable, suggesting the molecule could behave well in a living system.